Detalhe da pesquisa
1.
PI3K Isoform Immunotherapy for Solid Tumours.
Curr Top Microbiol Immunol
; 436: 369-392, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36243853
2.
Whole blood-based measurement of SARS-CoV-2-specific T cells reveals asymptomatic infection and vaccine immunogenicity in healthy subjects and patients with solid-organ cancers.
Immunology
; 165(2): 250-259, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34775604
3.
Treg-driven tumour control by PI3Kδ inhibition limits myeloid-derived suppressor cell expansion.
Br J Cancer
; 127(9): 1595-1602, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35986086
4.
Molecular characterization of HLA class II binding to the LAG-3 T cell co-inhibitory receptor.
Eur J Immunol
; 51(2): 331-341, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32920841
5.
Pouring petrol on the flames: Using oncolytic virotherapies to enhance tumour immunogenicity.
Immunology
; 163(4): 389-398, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33638871
6.
Sequential targeting of PI3Kδ and LAG3 as an effective anti-cancer approach.
Br J Cancer
; 125(4): 467-469, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33824480
7.
Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cells.
Br J Cancer
; 124(9): 1552-1555, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33674735
8.
Human leukocyte antigen (HLA) class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope.
J Biol Chem
; 294(52): 20246-20258, 2019 12 27.
Artigo
Inglês
| MEDLINE | ID: mdl-31619516
9.
Primary breast tumours but not lung metastases induce protective anti-tumour immune responses after Treg-depletion.
Cancer Immunol Immunother
; 69(10): 2063-2073, 2020 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-32447412
10.
Regulatory T cells in cancer: where are we now?
Immunology
; 157(3): 187-189, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-31225653
11.
The nature of the human T cell response to the cancer antigen 5T4 is determined by the balance of regulatory and inflammatory T cells of the same antigen-specificity: implications for vaccine design.
Cancer Immunol Immunother
; 68(2): 247-256, 2019 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-30406375
12.
The Ussing chamber system for measuring intestinal permeability in health and disease.
BMC Gastroenterol
; 19(1): 98, 2019 Jun 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31221083
13.
Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation.
J Pathol
; 245(3): 270-282, 2018 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29603746
14.
T-cell modulation by cyclophosphamide for tumour therapy.
Immunology
; 154(1): 62-68, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29460448
15.
Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
Int J Cancer
; 143(1): 167-178, 2018 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29417587
16.
Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells.
Immunol Cell Biol
; 95(7): 620-629, 2017 08.
Artigo
Inglês
| MEDLINE | ID: mdl-28356569
17.
CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue.
PLoS Pathog
; 11(2): e1004641, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25654642
18.
A distinct chemokine axis does not account for enrichment of Foxp3(+) CD4(+) T cells in carcinogen-induced fibrosarcomas.
Immunology
; 145(1): 94-104, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25495686
19.
Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
Cancer Immunol Immunother
; 64(10): 1271-86, 2015 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-26122357
20.
The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment.
Gut
; 63(3): 515-24, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23665989